{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T13:03:05Z","timestamp":1744030985950},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Complement and antibody contribute to infection-enhancement and possible expanded cellular tropism of HIV-1 in vitro through a process requiring complement receptors. Until now, however, the ability of HIV-1 to bind complement receptors has not been documented or characterized. We investigated whether antibody and complement permitted HIV-1 to bind to the B lymphocyte receptor, CR2 (CD21), in an effort to learn more about infection-enhancement, and also because CR2 can mediate B cell proliferation and antigen localization in lymphoid organs in other systems. HIV-1 incubated with antibody and fresh human serum as a source of complement bound approximately 10-fold greater to cells expressing CR2 than to HIV-1-permissive cells lacking this receptor. A similar effect was observed using cells which expressed CR2 but no CD4. This binding was minimal in heat-inactivated and C3-deficient sera, and was significantly reduced by the anti-CR2 MoAb, OKB7, but not by the anti-CD4 MoAb, OKT4a. Thus, complement and antibody acted in concert to facilitate the binding of HIV-1 to CR2 independently of CD4. CD4-independent binding of HIV-1 to CR2 was not sufficient to produce infection in Raji-3 cells. Titres of antibodies mediating CR2 binding correlated with antibody titres as measured by immunofluorescenee (P &amp;lt; 0.01) and infection-enhancement (P &amp;lt; 0.05) but were discordant with titres of neutralizing antibodies, a result consistent with the utilization of CR2 for enhanced infection of cells. The ability of complement and antibody to facilitate the binding of HIV-1 to CR2 in the absence of CD4 provides new insights into mechanisms of HIV-1-induced immunopathogenesis and infection-enhancement.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb05855.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T17:52:54Z","timestamp":1280166774000},"page":"383-389","source":"Crossref","is-referenced-by-count":16,"title":["CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody"],"prefix":"10.1093","volume":"90","author":[{"given":"D C","family":"MONTEFIORI","sequence":"first","affiliation":[{"name":"Department of Pathology, Vanderbilt University Medical School, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"ZHOU","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vanderbilt University Medical School, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D I","family":"SHAFF","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vanderbilt University Medical School, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011618520575500_b1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.6330889","article-title":"Antibodies to the core protein of lymphadenopathy virus (LAV) in patients with AIDS","volume":"225","author":"Kalyanaraman","year":"1984","journal-title":"Science"},{"key":"2022011618520575500_b2","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1073\/pnas.82.16.5535","article-title":"High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states","volume":"82","author":"Kaminsky","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011618520575500_b3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.6324345","article-title":"Antibodies reactive with human T-lymphotropic retroviruses (HTLV-IIl) in the serum of patients with AIDS","volume":"224","author":"Sarngadharan","year":"1984","journal-title":"Science"},{"key":"2022011618520575500_b4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0065-2776(08)60665-3","article-title":"The immunopathogenesis of HIV infection","volume":"47","author":"Rosenberg","year":"1989","journal-title":"Adv Immunol"},{"key":"2022011618520575500_b5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/316072a0","article-title":"HTLV-III neutralizing antibodies in patients with AIDS and AIDS-related complex","volume":"316","author":"Robert-Guroff","year":"1985","journal-title":"Nature"},{"key":"2022011618520575500_b6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0167-5699(90)90144-X","article-title":"B-cell activation and HIV-1 infection: deeds and misdeeds","volume":"11","author":"Amadori","year":"1991","journal-title":"Immunol Today"},{"key":"2022011618520575500_b7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.bi.57.070188.001541","article-title":"Molecular organization and function of the complement system","volume":"57","author":"Muller-Eberhard","year":"1988","journal-title":"Ann Rev Biochem"},{"key":"2022011618520575500_b8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0167-5699(91)90011-H","article-title":"The role of C3 in the immune response","volume":"12","author":"Erdei","year":"1991","journal-title":"Immunol Today"},{"key":"2022011618520575500_b9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0065-2776(08)60654-9","article-title":"Structure and funtion of the complement receptors, CRI (CD35) and CR2 (CD21)","volume":"46","author":"Ahearn","year":"1989","journal-title":"Adv Immunol"},{"key":"2022011618520575500_b10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/jcm.22.6.908-911.1985","article-title":"Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type 111 evaluated with new bioassay systems","volume":"22","author":"Harada","year":"1985","journal-title":"J Clin Microbioi"},{"key":"2022011618520575500_b11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0042-6822(86)90392-2","article-title":"The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum","volume":"152","author":"Banapour","year":"1986","journal-title":"Virol"},{"key":"2022011618520575500_b12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00002030-199010000-00003","article-title":"Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937","volume":"4","author":"Reisinger","year":"1990","journal-title":"AIDS"},{"key":"2022011618520575500_b13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.173.5.1151","article-title":"Complement mediates human immunodeficiency virus type I infection of a human T cell line in a CD4- and antibody-independent fashion","volume":"173","author":"Boyer","year":"1991","journal-title":"J Exp Med"},{"key":"2022011618520575500_b14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.174.6.1417","article-title":"Human immunodeficiency virus type 1 activates the classical pathway of complement by direct Cl binding through specific sites in the transmembrane glycoprotein gp41","volume":"174","author":"Ebenbichler","year":"1991","journal-title":"J Exp Med"},{"key":"2022011618520575500_b15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI112688","article-title":"Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome","volume":"78","author":"Tausk","year":"1986","journal-title":"J Ciin Invest"},{"key":"2022011618520575500_b16","first-page":"500","article-title":"Evidence for activation of complement in patients with AIDS related complex (ARC) and\/or lymphadenopathy syndrome (LAS)","volume":"70","author":"Perricone","year":"1987","journal-title":"Ciin Exp Immunol"},{"key":"2022011618520575500_b17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/162.6.1227","article-title":"Activation of the complement system in human immunodeficiency syndrome infection: relevance of the classical pathway to pathogenesis and disease severity","volume":"162","author":"Senaldi","year":"1990","journal-title":"J Infect Dis"},{"key":"2022011618520575500_b18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(88)91657-1","article-title":"Antibody-dependent enhancement of human immunodeficiency virus type 1 infection","volume":"i","author":"Robinson","year":"1988","journal-title":"Lancet"},{"key":"2022011618520575500_b19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(90)90449-2","article-title":"Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors","volume":"175","author":"Robinson","year":"1990","journal-title":"Virology"},{"key":"2022011618520575500_b20","first-page":"33","article-title":"Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA synthesis and infectious virus release","volume":"2","author":"Robinson","year":"1989","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022011618520575500_b21","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.171.5.1791","article-title":"Complement receptor type 2 mediates enhancement of human immunodeficiency virus infection in Epstein-Barr virus-carrying B cells","volume":"171","author":"Tremblay","year":"1990","journal-title":"J Exp Med"},{"key":"2022011618520575500_b22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/jvi.65.1.541-545.1991","article-title":"Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human. Epstein-Barr virus-transformed B-lymphocytic cell line","volume":"65","author":"Gras","year":"1991","journal-title":"J Virol"},{"key":"2022011618520575500_b23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002030-199103000-00004","article-title":"Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation","volume":"5","author":"June","year":"1991","journal-title":"AIDS"},{"key":"2022011618520575500_b24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-199201000-00004","article-title":"Antibodies and complement enhance binding and uptake of HlV-l by human monocytes","volume":"6","author":"Bakker","year":"1992","journal-title":"AIDS"},{"key":"2022011618520575500_b25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.iy.06.040188.000505","article-title":"Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment","volume":"6","author":"Cooper","year":"1988","journal-title":"Ann Rev Immunol"},{"key":"2022011618520575500_b26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.133.2.678","article-title":"Expression of C3d receptors during human B cell differentiation: immunofiuorescence analysis with the HB-5 monoclonal antibody","volume":"133","author":"Tedder","year":"1984","journal-title":"J Immunol"},{"key":"2022011618520575500_b27","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.4049\/jimmunol.135.4.2687","article-title":"Human foUicular dendritic cells express CRI. CR2, and CR3 complement receptor antigens","volume":"135","author":"Reynes","year":"1985","journal-title":"J Immunol"},{"key":"2022011618520575500_b28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-065X.1980.tb01038.x","article-title":"The foUicular dendritic cell: its role in antigen presentation and in the generation of immunological memory","volume":"53","author":"Klaus","year":"1980","journal-title":"Immunol Rev"},{"key":"2022011618520575500_b29","first-page":"865","article-title":"Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes","volume":"146","author":"Fischer","year":"1991","journal-title":"Immunol"},{"key":"2022011618520575500_b30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AtDS","volume":"224","author":"Popovic","year":"1984","journal-title":"Science"},{"key":"2022011618520575500_b31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.2035026","article-title":"LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur","volume":"252","author":"Wain-Hobson","year":"1991","journal-title":"Science"},{"key":"2022011618520575500_b32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/jvi.64.1.113-119.1990","article-title":"Antibody-dependent enhancement of simian immunodeficiency virus infection in vitro by plasma from SIV-infected rhesus macaques","volume":"64","author":"Montefiori","year":"1990","journal-title":"J Virol"},{"key":"2022011618520575500_b33","article-title":"Augmentation of HIV-I neutralizing antibody by priming with gpl60 recombinant vaccinia and boosting with rgpl60","author":"Graham","journal-title":"J Infect Dis."},{"key":"2022011618520575500_b34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/jcm.26.2.231-235.1988","article-title":"Evaluation of antiviral drugs and neutralizing antibodies against human immunodeficiency virus by a rapid and sensitive microtiter infection assay","volume":"26","author":"Montefiori","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2022011618520575500_b35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0042-6822(86)90233-3","article-title":"Infection of the HTLV-II-bearing T cell line C3 with HTLV-III\/LAV is highly permissive and lytic","volume":"155","author":"Montefiori","year":"1986","journal-title":"Virology"},{"key":"2022011618520575500_b36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1084\/jem.174.6.1299","article-title":"Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2","volume":"174","author":"Martin","year":"1991","journal-title":"J Exp Med"},{"key":"2022011618520575500_b37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1084\/jem.173.1.55","article-title":"Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD 19","volume":"173","author":"Matsumoto","year":"1991","journal-title":"J Exp Med"},{"key":"2022011618520575500_b38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4049\/jimmunol.141.2.457","article-title":"Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes","volume":"141","author":"Carter","year":"1988","journal-title":"J Immunol"},{"key":"2022011618520575500_b39","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.141.8.2569","article-title":"CR2 ligands modulate human B cell activation","volume":"141","author":"Bohnsack","year":"1988","journal-title":"J Immunol"},{"key":"2022011618520575500_b40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0092-8674(89)90420-0","article-title":"Regulatory pathways governing HIV-1 replication","volume":"58","author":"Cullen","year":"1989","journal-title":"Cell"},{"key":"2022011618520575500_b41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/164.1.53","article-title":"Effects of the calcium channel blocker verapamil on human immunodeficiency virus type 1 replication in lymphoid cells","volume":"164","author":"Harbison","year":"1991","journal-title":"J Infect Dis"},{"key":"2022011618520575500_b42","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.4049\/jimmunol.138.11.3720","article-title":"Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity","volume":"138","author":"Martinez-Maza","year":"1987","journal-title":"J Immunol"},{"key":"2022011618520575500_b43","first-page":"193","article-title":"Lymphocyte locomotion and migration","volume":"28","author":"Parrot","year":"1981","journal-title":"Prog Allergy"},{"key":"2022011618520575500_b44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/354389a0","article-title":"Intraclonal generation of antibody mutants in germinal centres","volume":"354","author":"Jacob","year":"1991","journal-title":"Nature"},{"key":"2022011618520575500_b45","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.4049\/jimmunol.128.5.2243","article-title":"Mouse lymph node germinal centers contain a selected subset of the T cell-helper phenotype","volume":"128","author":"Rouse","year":"1982","journal-title":"J Immunol"},{"key":"2022011618520575500_b46","first-page":"378","volume-title":"Proceedings of Tenth Histocompatibility Workshop","author":"Knight","year":"1990"},{"key":"2022011618520575500_b47","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1073\/pnas.88.21.9838","article-title":"Lymphoid organs function as major reservoirs for human immunodeficiency virus","volume":"88","author":"Pantaleo","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011618520575500_b48","first-page":"9","article-title":"HTLV-III\/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS","volume":"123","author":"Tenner-Racz","year":"1986","journal-title":"Am J Pathol"},{"key":"2022011618520575500_b49","first-page":"15","article-title":"Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells","volume":"140","author":"Spiegel","year":"1992","journal-title":"Am J Pathol"},{"key":"2022011618520575500_b50","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/164.6.1051","article-title":"Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA","volume":"164","author":"Fox","year":"1991","journal-title":"J Infect Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb05855.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/90\/3\/383\/42212168\/j.1365-2249.1992.tb05855.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/90\/3\/383\/42212168\/j.1365-2249.1992.tb05855.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T09:56:33Z","timestamp":1685699793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/90\/3\/383\/6487959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb05855.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1992,12]]},"published":{"date-parts":[[1992,12]]}}}